JPS59500418A - 胃腸能動作用障害を回復する方法 - Google Patents

胃腸能動作用障害を回復する方法

Info

Publication number
JPS59500418A
JPS59500418A JP58501579A JP50157983A JPS59500418A JP S59500418 A JPS59500418 A JP S59500418A JP 58501579 A JP58501579 A JP 58501579A JP 50157983 A JP50157983 A JP 50157983A JP S59500418 A JPS59500418 A JP S59500418A
Authority
JP
Japan
Prior art keywords
opium
total weight
administration
result
functional
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP58501579A
Other languages
English (en)
Japanese (ja)
Other versions
JPH045647B2 (enExample
Inventor
クリ−ク・メアリ−・ジ−ン
フイツシユマン・ジヤツク
Original Assignee
ザ　ロツクフエラ−　ユニバ−シテイ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ザ　ロツクフエラ−　ユニバ−シテイ filed Critical ザ　ロツクフエラ−　ユニバ−シテイ
Publication of JPS59500418A publication Critical patent/JPS59500418A/ja
Publication of JPH045647B2 publication Critical patent/JPH045647B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/06—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
    • C07D489/08—Oxygen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pinball Game Machines (AREA)
  • Medicinal Preparation (AREA)
JP58501579A 1982-03-16 1983-03-14 胃腸能動作用障害を回復する方法 Granted JPS59500418A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US35882082A 1982-03-16 1982-03-16
US46411083A 1983-02-04 1983-02-04
US464110FREGB 1983-02-04
US358820FREGB 1983-02-04

Publications (2)

Publication Number Publication Date
JPS59500418A true JPS59500418A (ja) 1984-03-15
JPH045647B2 JPH045647B2 (enExample) 1992-02-03

Family

ID=27000205

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58501579A Granted JPS59500418A (ja) 1982-03-16 1983-03-14 胃腸能動作用障害を回復する方法

Country Status (6)

Country Link
EP (1) EP0103636B1 (enExample)
JP (1) JPS59500418A (enExample)
CA (1) CA1212323A (enExample)
DE (1) DE3381877D1 (enExample)
IT (1) IT1212714B (enExample)
WO (1) WO1983003197A1 (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009539837A (ja) * 2006-06-05 2009-11-19 オレキシジェン・セラピューティクス・インコーポレーテッド ナルトレキソンの徐放型配合物
JP2014129397A (ja) * 2002-04-05 2014-07-10 Euro-Celtique Sa オキシコドン及びナロキソンを含有する医薬製剤

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4477457A (en) * 1982-10-28 1984-10-16 E. I. Du Pont De Nemours And Company Method for inducing anorexia using nalmetrene
WO1987001282A2 (en) * 1985-09-06 1987-03-12 Key Pharmaceuticals, Inc. Method and composition for providing sustained opioid antagonism
DE3780819T2 (de) * 1987-09-10 1993-01-14 Univ Chicago Quaternaere derivate von noroxymorphon zur behandlung von uebelkeit und erbrechen.
DE19605590A1 (de) * 1996-02-15 1997-08-21 Inresa Arzneimittel Gmbh Verwendung eines transdermalen therapeutischen Naloxon-Systems (Naloxon TTS)
ATE211906T1 (de) * 1996-03-12 2002-02-15 Alza Corp Zusammensetzung und dosisform mit einem opioid- antagonisten
DE19651551C2 (de) 1996-12-11 2000-02-03 Klinge Co Chem Pharm Fab Opioidantagonisthaltige galenische Formulierung
US6274591B1 (en) 1997-11-03 2001-08-14 Joseph F. Foss Use of methylnaltrexone and related compounds
DK1041987T3 (da) 1997-12-22 2006-08-21 Euro Celtique Sa Oral farmaceutisk doseringsform omfattende en kombination af en opioid-agonist og naltrexon
US6375957B1 (en) 1997-12-22 2002-04-23 Euro-Celtique, S.A. Opioid agonist/opioid antagonist/acetaminophen combinations
IL136805A0 (en) 1997-12-22 2001-11-25 Euro Celtique Sa A method of preventing abuse of opioid dosage forms
ES2226933T3 (es) 1999-11-01 2005-04-01 John Rhodes Composicion para tratar el estreñimiento y el sindrome del intestino irritable.
NZ518684A (en) * 1999-11-29 2003-11-28 Adolor Corp Use of a peripheral mu opioid antagonist to treat or prevent ileus
US6469030B2 (en) 1999-11-29 2002-10-22 Adolor Corporation Methods for the treatment and prevention of ileus
US6716449B2 (en) 2000-02-08 2004-04-06 Euro-Celtique S.A. Controlled-release compositions containing opioid agonist and antagonist
US6696088B2 (en) 2000-02-08 2004-02-24 Euro-Celtique, S.A. Tamper-resistant oral opioid agonist formulations
DE60238756D1 (de) 2001-05-11 2011-02-10 Endo Pharmaceuticals Inc Opioid enthaltende arzneiform gegen missbrauch
AU2002323032B2 (en) 2001-08-06 2005-02-24 Euro-Celtique S.A. Opioid agonist formulations with releasable and sequestered antagonist
ES2528669T3 (es) 2003-04-08 2015-02-11 Progenics Pharmaceuticals, Inc. Formulaciones farmacéuticas que contienen metilnaltrexona
MY135852A (en) 2003-04-21 2008-07-31 Euro Celtique Sa Pharmaceutical products
MXPA05011557A (es) 2003-04-29 2006-03-09 Orexigen Therapeutics Inc Composiciones para afectar perdida de peso.
EP1702558A1 (en) 2005-02-28 2006-09-20 Euro-Celtique S.A. Method and device for the assessment of bowel function
US9662325B2 (en) 2005-03-07 2017-05-30 The University Of Chicago Use of opioid antagonists to attenuate endothelial cell proliferation and migration
US8524731B2 (en) 2005-03-07 2013-09-03 The University Of Chicago Use of opioid antagonists to attenuate endothelial cell proliferation and migration
US8518962B2 (en) 2005-03-07 2013-08-27 The University Of Chicago Use of opioid antagonists
CA2600350C (en) 2005-03-07 2015-02-10 The University Of Chicago Use of opioid antagonists to attenuate endothelial cell proliferation and migration
EP1926842A2 (en) 2005-05-20 2008-06-04 Electrolyser Corp. Acidic electrolyzed water production system and protection membrane
AR057325A1 (es) 2005-05-25 2007-11-28 Progenics Pharm Inc Sintesis de (s)-n-metilnaltrexona, composiciones farmaceuticas y usos
AR057035A1 (es) 2005-05-25 2007-11-14 Progenics Pharm Inc SíNTESIS DE (R)-N-METILNALTREXONA, COMPOSICIONES FARMACÉUTICAS Y USOS
CN101356176B (zh) * 2005-11-09 2011-12-21 东丽株式会社 功能性肠病的治疗或预防药
EP2292220A3 (en) 2005-11-22 2012-01-04 Orexigen Therapeutics, Inc. Composition and methods for increasing insulin sensitivity
US8916195B2 (en) 2006-06-05 2014-12-23 Orexigen Therapeutics, Inc. Sustained release formulation of naltrexone
DK2526932T3 (en) 2006-06-19 2017-07-17 Alpharma Pharmaceuticals Llc Pharmaceutical composition
TWI489984B (zh) 2006-08-04 2015-07-01 Wyeth Corp 用於非經腸道傳輸化合物之配方及其用途
AU2007319472B2 (en) 2006-11-09 2013-01-17 Nalpropion Pharmaceuticals Llc Methods Of Administering Weight Loss Medications
WO2008121352A2 (en) 2007-03-29 2008-10-09 Progenics Pharmaceuticals, Inc. Crystal forms of (r) -n-methylnaltrexone bromide and uses thereof
TWI553009B (zh) 2007-03-29 2016-10-11 普吉尼製藥公司 末梢性類鴉片受體拮抗劑及其用途
US8338446B2 (en) 2007-03-29 2012-12-25 Wyeth Llc Peripheral opioid receptor antagonists and uses thereof
EP2240489A1 (en) 2008-02-06 2010-10-20 Progenics Pharmaceuticals, Inc. Preparation and use of (r),(r)-2,2'-bis-methylnaltrexone
WO2009117669A2 (en) 2008-03-21 2009-09-24 The University Of Chicago Treatment with opioid antagonists and mtor inhibitors
US20110144145A1 (en) 2008-05-30 2011-06-16 Orexigen Therapeutics, Inc. Methods for treating visceral fat conditions
CA2676881C (en) 2008-09-30 2017-04-25 Wyeth Peripheral opioid receptor antagonists and uses thereof
KR20110133602A (ko) 2009-03-10 2011-12-13 유로-셀티큐 에스.에이. 옥시코돈 및 날록손을 포함하는 즉시 방출 제약 조성물
CN102724878A (zh) 2010-01-11 2012-10-10 奥雷西根治疗公司 在重度抑郁症患者中提供体重减轻疗法的方法
KR20220042241A (ko) 2012-06-06 2022-04-04 오렉시젠 세러퓨틱스 인크. 과체중 및 비만의 치료 방법
EA201600033A1 (ru) 2013-07-23 2016-10-31 Еуро-Селтик С.А. Комбинация оксикодона и налоксона для лечения боли у пациентов, страдающих от боли и заболевания, приводящего к дисбиозу кишечника и/или повышению риска транслокации кишечной микрофлоры
US8969371B1 (en) 2013-12-06 2015-03-03 Orexigen Therapeutics, Inc. Compositions and methods for weight loss in at risk patient populations

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3214341A (en) * 1962-01-15 1965-10-26 Feinstone Wolffe Harry Prolonged action medicament
JPS4961324A (enExample) * 1972-10-11 1974-06-14
JPS53119899A (en) * 1977-03-23 1978-10-19 Reckitt & Colmann Prod Ltd Morphine derivative
JPS53121798A (en) * 1977-03-23 1978-10-24 Reckitt & Colmann Prod Ltd Morphine derivative
JPS54117499A (en) * 1978-02-10 1979-09-12 Miles Lab 4*5 alphaaepoxymorphinanee66one compound* its manufacture and its pharmacological use
US4277605A (en) * 1980-03-07 1981-07-07 Bristol-Myers Company Chemical compounds

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3060086A (en) * 1958-07-21 1962-10-23 Abbott Lab Anti-diarrhea composition
US3254088A (en) 1961-03-14 1966-05-31 Lewenstein Morphine derivative
US3332950A (en) 1963-03-23 1967-07-25 Endo Lab 14-hydroxydihydronormorphinone derivatives
NL297631A (enExample) * 1963-06-03
US3320262A (en) 1964-09-22 1967-05-16 Lewenstein 14 hydroxy morphine and codeine carboxymethyloximes
US3896226A (en) 1971-11-26 1975-07-22 Lewinstein Evalina 6-methylene-6-desoxy dihydro morphine and codeine derivatives and pharmaceutically acceptable salts thereof, and use of the same as a narcotic antagonist
GB1522480A (en) * 1975-10-31 1978-08-23 British Ind Sand Rendering
GB1579818A (en) * 1977-06-07 1980-11-26 Yamanouchi Pharma Co Ltd Nifedipine-containing solid preparation composition
US4272541A (en) * 1978-06-02 1981-06-09 Miles Laboratories, Inc. 7,8 and 7-8 Substituted 4,5α-epoxymorphinan-6-one compounds, and methods of treating pain and drug dependence with them
US4176186A (en) 1978-07-28 1979-11-27 Boehringer Ingelheim Gmbh Quaternary derivatives of noroxymorphone which relieve intestinal immobility

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3214341A (en) * 1962-01-15 1965-10-26 Feinstone Wolffe Harry Prolonged action medicament
JPS4961324A (enExample) * 1972-10-11 1974-06-14
JPS53119899A (en) * 1977-03-23 1978-10-19 Reckitt & Colmann Prod Ltd Morphine derivative
JPS53121798A (en) * 1977-03-23 1978-10-24 Reckitt & Colmann Prod Ltd Morphine derivative
JPS54117499A (en) * 1978-02-10 1979-09-12 Miles Lab 4*5 alphaaepoxymorphinanee66one compound* its manufacture and its pharmacological use
US4277605A (en) * 1980-03-07 1981-07-07 Bristol-Myers Company Chemical compounds

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014129397A (ja) * 2002-04-05 2014-07-10 Euro-Celtique Sa オキシコドン及びナロキソンを含有する医薬製剤
JP2009539837A (ja) * 2006-06-05 2009-11-19 オレキシジェン・セラピューティクス・インコーポレーテッド ナルトレキソンの徐放型配合物
JP2016029111A (ja) * 2006-06-05 2016-03-03 オレキシジェン・セラピューティクス・インコーポレーテッド ナルトレキソンの徐放型配合物

Also Published As

Publication number Publication date
WO1983003197A1 (en) 1983-09-29
IT8320106A0 (it) 1983-03-16
EP0103636B1 (en) 1990-09-12
IT1212714B (it) 1989-11-30
DE3381877D1 (de) 1990-10-18
JPH045647B2 (enExample) 1992-02-03
EP0103636A1 (en) 1984-03-28
EP0103636A4 (en) 1986-03-04
CA1212323A (en) 1986-10-07

Similar Documents

Publication Publication Date Title
JPS59500418A (ja) 胃腸能動作用障害を回復する方法
US4987136A (en) Method for controlling gastrointestinal dysmotility
EP0185420A1 (en) Dihydrocodeine/ibuprofen pharmaceutical compositions and method
JPS62249923A (ja) パ−キンソン病、うつ病、ナルコレプシ−および脳器官精神症候群の抑制用薬剤およびその製造方法
US3849561A (en) Anti-peptic ulcer substance from corydalis tubers
WO2011066414A1 (en) Arachidonic acid analogs and methods for analgesic treatment using same
JPS5896036A (ja) 新ナフタレン誘導体の製法
JPS61500728A (ja) 食欲低下用医薬組成物
AU606424B2 (en) Use of dioxopiperidine derivatives as analgesics
JPS58164583A (ja) フエノキシプロパノ−ルアミン誘導体
TW383222B (en) Pharmaceutical composition of bicycloheptane derivatives
US2853418A (en) Hypnotic composition comprising a barbiturate and beta, beta-methyl ethyl glutarimide
EP0040947B1 (en) Use of guanidines for manufacturing antidiarrhoeal medicaments and antidiarrhoeal compositions containing these guanidines
CN110582278A (zh) 药物组合物及其用途
BATTERMAN et al. Demerol: A Substitute for Morphine in the Treatment of Postoperative Pain
US2991225A (en) Omicron-methylbenzhydryl-beta-dimethylaminoethyl ether process and composition for symptomatic relief of the syndrome of parkinsonism and of spastic skeletal muscle disorders
US3035976A (en) Bronchodilator composition and method
JP2000026313A (ja) 消化管運動抑制剤
Servedio The use of flavoxate in cystitis and renal colic
US3666861A (en) Methods for treating migraine which use 2-(2{40 ,6{40 -dichlorophenyl-amino)-1,3-diszacyclopentene-(2)
WO1991001733A1 (fr) Remede
US3709995A (en) Method of producing gastrointestinal spasmolytic activity with alkylphenoxypoly(ethyleneoxy)ethanols
US3495005A (en) Compositions and methods for suppressing appetite with combinations of amphetamine and thioridazine
US3278381A (en) 5 amino-1-phenyltetrazole muscle relaxant preparations
US3257277A (en) Synergistic antihypertensive compositions